Centene Co. (NYSE:CNC) Shares Sold by Van ECK Associates Corp

Van ECK Associates Corp cut its holdings in shares of Centene Co. (NYSE:CNC) by 6.0% in the 3rd quarter, Holdings Channel reports. The fund owned 82,638 shares of the company’s stock after selling 5,263 shares during the period. Van ECK Associates Corp’s holdings in Centene were worth $6,221,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Park Place Capital Corp increased its holdings in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC raised its holdings in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc bought a new stake in Centene in the second quarter valued at about $33,000. Riverview Trust Co lifted its holdings in Centene by 154.6% during the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after buying an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Centene in the 2nd quarter worth approximately $36,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on CNC shares. Stephens reaffirmed an “equal weight” rating and issued a $78.00 price objective on shares of Centene in a report on Monday, August 5th. Jefferies Financial Group downgraded shares of Centene from a “buy” rating to a “hold” rating and reduced their price target for the company from $83.00 to $69.00 in a report on Wednesday, July 24th. Robert W. Baird cut their price objective on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Wells Fargo & Company decreased their target price on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $90.00 price target on shares of Centene in a research report on Tuesday, October 1st. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Centene presently has an average rating of “Moderate Buy” and a consensus target price of $83.92.

Centene Price Performance

NYSE CNC opened at $62.52 on Friday. Centene Co. has a 1 year low of $59.77 and a 1 year high of $81.42. The business’s fifty day moving average is $70.40 and its two-hundred day moving average is $71.75. The stock has a market capitalization of $31.56 billion, a P/E ratio of 10.85, a P/E/G ratio of 0.88 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.